Active Shortage

BYOOVIZ

SAMSUNG BIOEPIS CO., LTD

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of BYOOVIZ in Canada?

Yes. BYOOVIZ 10MG has an active shortage reported to Health Canada (last updated June 9, 2026).

When will BYOOVIZ be available again?

The manufacturer's estimated resolution date is June 30, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file4 products

Expected resolution~9 months remaining (estimate)

Affected strength10MG

Last updated2026-06-09

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

LUCENTIS

NOVARTIS PHARMACEUTICALS CANADA INC

10MG · DIN 02425629

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

RANVU

APOTEX INC

10MG · DIN 02568942

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

RANOPTO

TEVA CANADA LIMITED

10MG · DIN 02542250

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

SUSVIMO

HOFFMANN-LA ROCHE LIMITED

100MG · DIN 02530589

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2027-06-30

~9 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02525852

Strength

10MG

Dosage Form

SOLUTION

Route

INTRAVITREAL

Active Ingredient

RANIBIZUMAB

Tier

Unrated

Last Updated

2026-06-09

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Other Products from SAMSUNG BIOEPIS CO., LTD

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

100MG · DIN 02522829

400MG · DIN 02522837

50MG · DIN 02455323

50MG · DIN 02455331

40MG · DIN 02533472

40MG · DIN 02473097